» Articles » PMID: 15172923

Application of Economic Analysis to Diabetes and Diabetes Care

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2004 Jun 3
PMID 15172923
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Facing limited resources and increases in demand from competing programs, policymakers and health care providers seek guidance from economic studies on how to use health care resources wisely. Previous economic studies mainly focused on estimating the cost of diabetes and cost-effectiveness of different interventions. These studies found that diabetes is costly and that its cost will continue to increase; thus, more resources should be devoted to research aimed at finding effective means to prevent the disease and its complications. In addition, the cost-effectiveness of interventions varies greatly in terms of quality-adjusted life-years gained; therefore, efficient uses of resources should be an important consideration when interventions are prioritized. The need for economic studies will continue to grow because of increasing demand for limited resources from the growing number of interventions available. Future studies should be of better quality and broadened in areas of research.

Citing Articles

Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.

Stegbauer C, Falivena C, Moreno A, Hentschel A, Rosenmoller M, Heise T BMC Health Serv Res. 2020; 20(1):1043.

PMID: 33198734 PMC: 7667793. DOI: 10.1186/s12913-020-05897-w.


Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies.

Bagepally B, Chaikledkaew U, Gurav Y, Anothaisintawee T, Youngkong S, Chaiyakunapruk N BMJ Open Diabetes Res Care. 2020; 8(1).

PMID: 32690574 PMC: 7371226. DOI: 10.1136/bmjdrc-2019-001020.


The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method.

Moradi N, Rashidian A, Nosratnejad S, Olyaeemanesh A, Zanganeh M, Zarei L Pharmacoecon Open. 2019; 3(3):311-319.

PMID: 30617954 PMC: 6710303. DOI: 10.1007/s41669-018-0111-2.


Draft National Health Policy of India and Determining Cost-effectiveness Threshold.

Sakharkar P J Basic Clin Pharm. 2017; 8(1):1-3.

PMID: 28104966 PMC: 5201057. DOI: 10.4103/0976-0105.195078.


Peer-Led, Empowerment-Based Approach to Self-Management Efforts in Diabetes (PLEASED): A Randomized Controlled Trial in an African American Community.

Tang T, Funnell M, Sinco B, Spencer M, Heisler M Ann Fam Med. 2015; 13 Suppl 1:S27-35.

PMID: 26304969 PMC: 4648139. DOI: 10.1370/afm.1819.